Covalent flexible peptide docking in Rosetta

Barr Tivon, Ronen Gabizon, Bente A. Somsen, Peter J. Cossar, Christian Ottmann, Nir London (Corresponding author)

Research output: Contribution to journalArticleAcademicpeer-review

1 Downloads (Pure)

Abstract

Electrophilic peptides that form an irreversible covalent bond with their target have great potential for binding targets that have been previously considered undruggable. However, the discovery of such peptides remains a challenge. Here, we present Rosetta CovPepDock, a computational pipeline for peptide docking that incorporates covalent binding between the peptide and a receptor cysteine. We applied CovPepDock retrospectively to a dataset of 115 disulfide-bound peptides and a dataset of 54 electrophilic peptides. It produced a top-five scoring, near-native model, in 89% and 100% of the cases when docking from the native conformation, and 20% and 90% when docking from an extended peptide conformation, respectively. In addition, we developed a protocol for designing electrophilic peptide binders based on known non-covalent binders or protein-protein interfaces. We identified 7154 peptide candidates in the PDB for application of this protocol. As a proof-of-concept we validated the protocol on the non-covalent complex of 14-3-3σ and YAP1 phosphopeptide. The protocol identified seven highly potent and selective irreversible peptide binders. The predicted binding mode of one of the peptides was validated using X-ray crystallography. This case-study demonstrates the utility and impact of CovPepDock. It suggests that many new electrophilic peptide binders can be rapidly discovered, with significant potential as therapeutic molecules and chemical probes. This journal is

Original languageEnglish
Pages (from-to)10836-10847
Number of pages12
JournalChemical Science
Volume12
Issue number32
DOIs
Publication statusPublished - 28 Aug 2021

Bibliographical note

Funding Information:
N. L. is the incumbent of the Alan and Laraine Fischer Career Development Chair. N. L. thanks the Israel Science Foundation for funding (grant no. 2462/19), The Israel Cancer Research Fund, and the Moross integrated cancer center. N. L. is also supported by the Helen and Martin Kimmel Center for Molecular Design, Joel and Mady Dukler Fund for Cancer Research, the Estate of Emile Mimran and Virgin JustGiving and the George Schwartzman Fund. C. O. acknowledges funding from the European Union through the Eurotech Postdoctoral Fellow program (Marie Skłodowska-Curie Co. funded, grant 754462) and the Netherlands Organization for Scientic Research Echo grant (grant 711.017.014).

Fingerprint

Dive into the research topics of 'Covalent flexible peptide docking in Rosetta'. Together they form a unique fingerprint.

Cite this